| Ytd | 3.00% | |
| 1y | -81.62% |
| Open | 0.10 | Prev Close | 0.10 | Low | 0.10 | High | 0.11 | Mkt Cap | 14.86M |
| Vol | 0.00 | Avg Vol | 15.80M | EPS | -0.10 | P/E | -1.03 | Forward P/E | -1.85 |
| Beta | 2.08 | Short Ratio | 3.25 | Inst. Own | 103.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 0.15 | 200-d Avg | 0.46 | 1yr Est | 5.92 |
APLT News
Applied Therapeutics (NASDAQ: APLT - Get Free Report) and Cartesian Therapeutics (NASDAQ: RNAC - Get
CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted t
CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle” or “Parent”) to
NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”
CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle” or “Parent”) to
CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle” or “Parent”) to
Applied Therapeutics Inc. (NASDAQ: APLT - Get Free Report) was the target of a large decrease in sho
Applied Therapeutics (APLT) witnesses a hammer chart pattern, indicating support found by the stock
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Applied Therapeutic's lead drug candidate, govorestat, is a novel central nervous system penetrant A
Applied Therapeutics (APLT) might move higher on growing optimism about its earnings prospects, whic
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”
Applied Therapeutics, Inc. (NASDAQ: APLT) stock is trading lower on Thursday, with a session volume
– Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether c
The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company)
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmace
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reducti
Small-cap stocks are surging ahead of the expected interest rate cut by the Federal Reserve, outperf
During Wednesday's trading, 517 companies set new 52-week lows.
On Friday, 404 stocks made new 52-week lows.
Wednesday's session saw 269 companies set new 52-week lows.
Monday's session saw 84 companies set new 52-week lows.
Stocks That Hit 52-Week Highs On Wednesday